Fingerprint
Dive into the research topics of 'Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Patients' and doctors' preferences for adjuvant chemotherapy in resected non-small-cell lung cancer: What makes it worthwhile?
P. Blinman, B. Hughes, C. Crombie, T. Christmas, M. Hudson, A.S. Veillard, N. Muljadi, Michael Millward, G. Wright, P. Flynn, M. Windsor, M. Stockler, S.A. Mclachlan
Research output: Contribution to journal › Article › peer-review
18
Citations
(Web of Science)